Search Programme
Results for CCC
Monday, September 21, 2026
- 08:00–09:00 Personalizing immunosuppression in liver transplantation: From microbiome to malignancy
-
08:00–09:00
Vasculopathy: A tale of three organs
What should we continue to learn from renal allograft pathologyMariam Alexander (US)
-
09:15–10:30
Beyond survival: Addressing mental health in transplantation
Why survival alone is not sufficient for transplant successsMariel Nöhre (DE)Psychological distress across the transplant journeyIris Fontanilla (NZ)Practical strategies for integrating mental health in transplant careMing Hwei Yek (US)Panel DiscussionDiscussion Period (AU)
-
09:15–10:30
Dedicated donor care units: Centralized donor transfer and outcome optimization
Chairs: David Thomson (ZA); Dan Harvey (GB)
25 years of innovation: The St. Louis donor care unitGary F. Marklin (US)The US donor care unit landscapeJennifer Prinz (US)Panel DiscussionDiscussion Period (AU) -
11:00–12:00
DCD: Controlled and uncontrolled—Where are we going?
Chair: Kenneth J. Woodside (US)
Role of ICU physiciansSara Alcantara Carmona (ES)Question PeriodDiscussion Period (AU) -
11:00–12:00
The -omic era in allograft pathology
Does metabolic phenotype in the kidney affect transplant outcome?Ana Konvalinka (CA)Endogenous peptides in T cell allorecognition and beyond – Lessons from preclinical modelsAlexandra Sharland (AU)
-
11:00–12:00
Transplantation journals: Updates and opportunities
Chairs: Stefan Tullius (US); Fadi Issa (GB)
Structure, achievements, goals – Getting your work published, recognized and highlightedStefan Tullius (US)Transplant-Direct: The online campaign journal with an own agendaEdward Geissler (DE)AI and publishing: When, how and what is legit?Germaine Wong (AU) -
13:30–15:00
The mentorship mosaic: Fostering growth in transplant training and practice
Chairs: Sarah Tsou (US); Natasha Rogers (AU)
Panel discussantFriederike Martin (DE)Panel discussantGomathy Narasimhan (IN)Panel discussantKhushboo Saxena (IN) -
13:30–15:00
Building high-performing transplant registries: Global consensus recommendations and a practical maturity framework
Chair: Sang Joseph Kim (CA)
Opening remarks and overview: From fragmented data to global alignment. Why transplant registries need a shared frameworkSang Joseph Kim (CA)Creating a transplant registry: Defining purpose, scope, and sustainable infrastructureGermaine Wong (AU)Establishing trust: Governance, ethics, and legal architecture of transplant registriesAxel Rahmel (DE)From aspirational standards to practical assessment: Introducing the transplant registry maturity modelYee Lu (US)Panel DiscussionDiscussion Period (AU)PanelistNicole Jane Scholes-Robertson (AU) -
15:30–16:30
Advancing ABO histocompatibility: Needs and solutions
ABO antigens and antibodies: Updating old dogmasAnne Halpin (CA)ABO incompatible kidney transplantation, strategies and successesMarta Crespo Barrio (ES)
-
15:30–16:30
Expanding donor access: The impact of ECMO in thoracic transplantation a TTS/ISHLT Conjunct Session
Chairs: Pablo Sanchez (US); Raj Ramanan (US)
The role of NRP and machine perfusion in cardiothoracic transplantationSandra Lindstedt Ingemansson (SE) -
16:45–18:00
Sex, cancer, and the graft: What women need most from transplant care
Chair: Karen Keung (AU)
Do women do better or worse – What the data say across cancer and transplant?Brenda Maria Rosales (AU)Post transplant care: Patient perspectivesNicole Jane Scholes-Robertson (AU) -
16:45–18:00
Transplant without borders: Collaborative solutions for global kidney care
The global interdependence of health and the burden of kidney disease as a pressing public health priorityBenita Padilla (PH)Transplant knowledge and skills transfer: the role of collaborative partnerships in reducing disparities in kidney disease-related morbidity and mortalityShyam Bihari Bansal (IN)Overcoming the challenges in achieving equity in global access to kidney transplantationBeatriz Domínguez-Gil (ES)
Tuesday, September 22, 2026
-
08:00–09:00
Pediatric treatments on the Horizon
Partial heart transplant in childrenTaufiek Konrad Rajab (US)Regulatory cell therapy for solid organ transplantationFadi Issa (GB)
-
11:00–12:00
Optimizing and utilizing old organ donors
Setting the stage: Older organs - clinical need, ethical and economic considerationsKrista Lentine (US)Objective quality criteria of old organsVarvara Kirchner (US)
-
11:00–12:00
The journey to clinical xenotransplantation
Development of the gene edited pigs to get us to the clinicPeter Cowan (AU)The road to regulatory approval for clinical transplantationMuhammad Mohiuddin (US)
-
13:30–15:00
Global collaboration in organ transplantation: Advancing ethical access, innovation, and sustainability
Capacity building in low-resource settingsMedhat Askar (QA)
-
13:30–15:00
Emerging infectious diseases in transplant ID
Climate change and the changing epidemiology of transplant infectionsWanessa T. Clemente (BR)New outbreaks of old diseases: Measles and other re-emerging threats in transplantationCameron Wolfe (US)Disease X and vaccineDeepali Kumar (CA)
-
13:30–15:00
Life after transplant: Supporting movement, confidence, and long-term recovery across all levels of ability (WTGF)
Clinical perspective: Encouraging safe physical activity after transplantGeoffrey McCaughan (AU)Panel discussion: Supporting all patients to moveDiscussion Period (AU)
-
13:30–15:05
ISOT: Redefining organ transplantation in resource-limited settings: Access, affordability, and global leadership from India - Part 1
Chairs: Ravi Mohanka (IN); Swarnalatha Guditi (IN); Divyesh Engineer (IN); Amit Pasari (IN); Abi Abraham (IN); Amol Bhawane (IN); Sreebhushan Raju (IN); Manish Balwani (IN); Feroz Aziz (IN)
Government reforms to increase access to organ transplantation: Policy innovations and outcomesAnil Kumar (IN)Optimizing transplant outcomes through cost-effective immunological evaluation in LMICsManoj Gumber (IN) -
15:30–16:30
Solving immune problems for the life of the allograft
Single cell spatial technologies in kidney allograft pathology- inflammation, fibrosis and beyondMariam Alexander (US)Direct and indirect allorecognition – more alike than we thought?Gavin Pettigrew (GB)
-
15:30–16:30
TTS-ISN: Pregnancy in renal transplant recipients - Outcomes, barriers, and clinical management
The pregnancy after renal transplantation OUTcomes registry (PARTOUT) in the Netherlands with granular dataMargriet de Jong (NL)Assessing risk and overcoming barriers in pregnancy after kidney transplantationShilpanjali Jesudason (AU)
-
15:35–18:10
ISOT: Redefining organ transplantation in resource-limited settings: Access, affordability, and global leadership from India - Part 2
Chairs: Shruti Tapiawala (IN); Gireesh MS (IN); Mohan Patel (IN); Raj Kanwar Yadav (IN); Dhananjai Agarwal (IN); Dhananjaya KL (IN); Pranjal Kashiv (IN); Ashish Sharma (IN); Narayan Prasad (IN); Arpita Ray Chaudhury (IN); Vrushali Deshpande (IN); Vikas Jain (IN); Sourabh Sharma (IN); Pankaj Shah (IN)
Making ABO-incompatible transplantation affordable for low- and middle-income countries: Scalable cost-reduction strategiesDeepak S. Ray (IN)HLA desensitization in transplantation in LMIC: Balancing access, cost, and clinical outcomesUmapati Hegde (IN)Integrating cell-free DNA surveillance into cost-effective organ transplantation pathways in LMIC settingsPratik Das (IN)Gender disparity in organ transplantation: Insights and lessons from LMICKhushboo Saxena (IN)Pioneering surgical techniques in transplantation: The global south contribution to global practicePranjal Modi (IN)ISOT position statements for increasing access to transplantationJigar Shrimali (IN) -
16:45–18:00
Multidisciplinary: Leveraging shared infrastructure for hematopoietic stem cell and solid organ transplantation
Immunologic bridgeRajdeep Das (US)One pathogen, two populationsMonica Slavin (AU)Beyond the graftTeun van Gelder (NL)Panel discussion on global perspectives on integration and innovationDiscussion Period (AU)
-
16:45–18:00
Approaching and navigating difficult conversations with transplant patients
Conversations around kidney transplant evaluation: Who and how to communicate non-eligibility for transplantRhiannon Reed (US)Palliative care post-transplant: Throughout patient journey and symptom managementKathryn Ducharlet (AU)Navigating through organ failure to transplant: Liver transplantSuk Kyun Hong (KR)Navigating conversations on cardiac mechanical support therapy to heart transplantShunichi Nakagawa (US)
Wednesday, September 23, 2026
- 08:00–09:00 Metabolic dysfunction and liver transplantation
-
08:00–09:00
Key components of an ideal high volume transplant program setup: A global surgical perspective
The European perspectiveJiri Fronek (CZ)The Oceania perspectiveHenry Pleass (AU)Panel discussionDiscussion Period (AU)
-
08:00–09:30
CMV and BK virus in transplant recipients: Pearls from the guidelines and emerging frontiers
Chairs: Wanessa T. Clemente (BR); Jeremy Chapman (AU)
Pearls from the BK guidelinesNassim Kamar (FR)Pearls from the CMV guidelinesCamille N. Kotton (US)Beyond the guidelines- new developments and future directions: BKGermaine Wong (AU)Panel discussion: challenging BK case, challenging CMV caseDiscussion Period (AU) -
09:15–10:15
From allorecognition to allocation: Moving toward more individualized kidney transplant matching
Importance of HLA beyond the A/B/DRAnat Tambur (US)Beyond HLA: Expanding the immunologic landscapeToby Coates (AU)Precision risk stratificationWai Lim (AU)
-
09:15–10:15
Transplantation beyond traditional publications
Chairs: Stefan Tullius (US); Macey L. Levan (US)
Editorial fellowships: A great opportunity to be involvedMelanie Wyld (AU)Topic highlights – Article seriesCamille N. Kotton (US)Panel discussionDiscussion Period (AU) -
10:45–12:00
Expanding horizons in pancreas transplantation: Outcomes, techniques, and program development
Chairs: Pablo Uva (AR); Toby Coates (AU)
-
13:45–15:15
Pediatric cholestatic liver disease around the world
Chairs: Gabriel E. Gondolesi (US); Manuel Rodriguez-Davalos (US)
Biliary atresia - whats happening in Latin America. Access to KPE and transplantationMonserrat Arreola Gutierrez (MX)Progressive familiar intrahepatic cholestasis differences around the world and the role of medical vs. surgical therapyMohamed Rela (IN)Primary sclerosing cholangiotis in children and adolescentMichael Stormon (AU) -
13:45–15:15
Organ donation following MAID (VAD/euthanasia)
Chair: Helen Opdam (AU)
Panelist representing CanadaMatthew Weiss (CA)Panelist representing AustraliaWade Stedman (AU)